Potential therapeutic target for controlling high blood sugar identifiedMarch 19th, 2009 - 4:33 pm ICT by ANI
Washington, Mar 19 (ANI): Scientists from University of Michigan School of Kinesiology have identified a potential therapeutic target for controlling high blood sugar levels.
The researchers have come across certain proteins that could lead to new drug therapies.
Understanding these proteins may also help in devising more effective exercise to prevent Type 2 diabetes, and such other health problems as are associated with having high blood sugar.
Lead researcher Gregory Cartee, professor at the University of Michigan School of Kinesiology, has revealed that Insulin and muscle contractions are the two most important stimuli to increase glucose transport into muscle cells. Cells then use the glucose for energy.
However, they aren”t entirely sure how this works.
Cartee and colleague Katsuhiko Funai, a graduate student researcher in kinesiology, looked at how two different proteins believed to be important in stimulating glucose transport react to two different enzymes also related to glucose transport.
The researchers objective was to understand the contribution of the two proteins, AS160 and TBC1D1, in skeletal muscle stimulated by insulin.
“We”re trying to rule out or rule in which proteins are important with exercise,” Cartee said.
The study revealed that the protein TBC1D1 was more important for exercise-stimulated glucose transport, and suggested that the second protein, AS160, might be less important for this effect of exercise.
By focusing on the protein that works bestin this case, TBC1Dscientists can develop ways to make that protein work better for insulin-resistant people.
“Almost all people with Type 2 diabetes have muscle insulin resistance,” he said.
“This doesn”t cause diabetes by itself, but it’’s an essential component that contributes to Type 2 diabetes. This impacts millions of people. Even for people who aren”t diabetic, insulin resistance is associated with lots of health problems,” he added.
The researchers would be conducting further studies to understand what exactly TBC1D1 does to promote glucose transport during and after exercise. (ANI)
- Micro-RNA that regulates insulin in obesity identified - Apr 01, 2011
- Pair of liver molecules could control diabetes - Apr 09, 2012
- Biochemical to treat diabetes discovered - Jul 16, 2012
- Link between high-fat diets, type 2 diabetes clarified - Apr 12, 2011
- Potential new target for diabetes treatment identified - Nov 03, 2010
- Fat, not sugar, contributes to Type-2 diabetes - Sep 04, 2012
- Dieting alone cannot help stave off type 2 diabetes - May 28, 2010
- HIV drugs 'lead to insulin resistance' - Nov 23, 2010
- Potential new non-insulin treatment for type 1 diabetes found - Mar 25, 2011
- Bones may have bigger role in diabetes than believed - Jul 23, 2010
- Missing sugar molecule 'increases diabetes risk' - Feb 25, 2011
- Boosting insulin levels can restore muscle-building process in elderly - Sep 26, 2009
- Scientists reveal new clues to origin of diabetes - Oct 13, 2010
- Insulin-releasing switch found - Mar 16, 2011
- Scientists identify new glucose-regulating protein linked with diabetes - May 29, 2009
Tags: blood sugar levels, cartee, cause diabetes, diabetic insulin, drug therapies, glucose transport, graduate student researcher, health problems, high blood sugar, high blood sugar levels, insulin resistance, kinesiology, michigan school, muscle cells, muscle contractions, protein work, skeletal muscle, stimuli, therapeutic target, type 2 diabetes